Back to 
BAMCO Inc.
BAMCO Inc.
LGND
Showing 0 of 3 quarters
Position history for BAMCO Inc.'s holdings in Ligand Pharmaceuticals Incorporated
No. BAMCO exited its LGND (Ligand Pharmaceuticals) position in Q3 2019. Its Q2 2019 13F listed 497 shares worth $57,000. BAMCO first reported LGND in Q1 2019 and held it in 2 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.